SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys영국의 SARS-CoV-2 감염 및 백신 효과(REACT-1): 일련의 횡단면 무작위 커뮤니티 설문조사Article Published on 2022-04-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Administered Adults age assessment B.1.617.2 BNT162b2 Breakthrough infection breakthrough infections ChAdOx1 ChAdOx1 nCoV-19 children commenced Community community transmission contributed COVID-19 epidemic COVID-19 vaccine CrI cross-sectional cross-sectional survey Data collection declined delta variant Department dose driving Effectiveness England General population highest household size increased risk individual individuals Infection less Mutation nose swab Older Oxford-AstraZeneca participant Pfizer-BioNTech positive Prevalence random reduce Reproduction number risk RT-PCR SARS-CoV-2 SARS-CoV-2 epidemic SARS-COV-2 infection SARS-CoV-2 transmission second dose sequenced single dose Spike protein Spread Swab swabs the spike protein vaccination vaccination rate vaccination rates Vaccine vaccines combined variant [DOI] 10.1016/S2213-2600(21)00542-7 PMC 바로가기 [Article Type] Article